These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36573384)

  • 1. Correlation Between Third Dose of COVID-19 Vaccines and Regional Case Fatality Rates During the Omicron Wave in Korea.
    Jang Y; Kim IJ; Moon SS; Kim SB; Lee J
    J Korean Med Sci; 2022 Dec; 37(50):e347. PubMed ID: 36573384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination.
    Martín-Sánchez V; Ruiz-Garcia A; Vitelli-Storelli F; Serrano-Cumplido A; Barquilla-Garcia A; Micó-Pérez RM; Olmo-Quintana V; Calderón-Montero A; Segura-Fragoso A
    Semergen; 2023 Oct; 49(7):102026. PubMed ID: 37356278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
    Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
    J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
    Shi HJ; Yang J; Eom JS; Ko JH; Peck KR; Kim UJ; Jung SI; Kim S; Seok H; Hyun M; Kim HA; Kim B; Joo EJ; Cheong HS; Jun CH; Wi YM; Kim J; Kym S; Lim S; Park Y
    J Korean Med Sci; 2023 Jul; 38(28):e217. PubMed ID: 37463688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
    Lim DS; Choe YJ; Man Kim Y; Lee SE; Jang EJ; Kim J; Park YJ
    Emerg Infect Dis; 2022 Aug; 28(8):1731-1734. PubMed ID: 35798007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Confirmed COVID-19 Cases in the Korean Military Before and After the Emergence of the Omicron Variant.
    Shin DH; Jang H; Lee S; Choi BS; Kim D; Oh HS
    J Korean Med Sci; 2022 Aug; 37(34):e260. PubMed ID: 36038957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021.
    Shim E
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.
    Newall AT; Leong RNF; Nazareno A; Muscatello DJ; Wood JG; Kim WJ
    Int J Infect Dis; 2020 Dec; 101():306-311. PubMed ID: 33011281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.
    Zhou C; Wheelock ÅM; Zhang C; Ma J; Dong K; Pan J; Li Z; Liang W; Gao J; Xu L
    Front Public Health; 2023; 11():1150095. PubMed ID: 37143970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
    Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccination in Korea: Past, Present, and the Way Forward.
    Nham E; Song JY; Noh JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2022 Dec; 37(47):e351. PubMed ID: 36472087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are the subsequent impacts on and new challenges for healthcare systems?
    Karako K; Song P; Chen Y; Karako T
    Biosci Trends; 2022; 16(6):381-385. PubMed ID: 36567122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil.
    Passarelli-Araujo H; Pott-Junior H; Susuki AM; Olak AS; Pescim RR; Tomimatsu MFAI; Volce CJ; Neves MAZ; Silva FF; Narciso SG; Aschner M; Paoliello MMB; Urbano MR
    Am J Infect Control; 2022 May; 50(5):491-496. PubMed ID: 35192917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.
    Yi S; Choe YJ; Kim J; Kim YY; Kim RK; Jang EJ; Lim DS; Byeon HR; Lee S; Park E; Kim SJ; Park YJ
    Emerg Infect Dis; 2022 Mar; 28(3):753-756. PubMed ID: 35202529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Song JS; Lee J; Kim M; Jeong HS; Kim MS; Kim SG; Yoo HN; Lee JJ; Lee HY; Lee SE; Kim EJ; Rhee JE; Kim IH; Park YJ
    Emerg Infect Dis; 2022 Mar; 28(3):756-759. PubMed ID: 35107418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Country-specific determinants for COVID-19 case fatality rate and response strategies from a global perspective: an interpretable machine learning framework.
    Zhou C; Wheelock ÅM; Zhang C; Ma J; Li Z; Liang W; Gao J; Xu L
    Popul Health Metr; 2024 Jun; 22(1):10. PubMed ID: 38831424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ
    Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
    Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
    EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.